DUBLIN--(BUSINESS WIRE)--The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
The healthcare sector is on the cusp of a revolution with the latest advancements in diagnostic technologies geared towards combatting antimicrobial resistance (AMR). This new comprehensive research publication analyzes the burgeoning market and the potential these technologies hold in the fight against one of the most pressing healthcare challenges of our time.
This report presents an in-depth analysis of the AMR diagnostic market, providing a clear understanding of the various diagnostic methods emerging to identify pathogens and infections. It dissects the new diagnostic technologies beyond gene sequencing that are gaining traction in this evolving market landscape.
The research underscores the strategic market opportunities against AMR by detailing the six key large pathogen opportunities poised for significant growth. This is an indispensable insight for industry investors and healthcare stakeholders seeking to stay ahead of the curve in a rapidly changing market.
Furthermore, the report offers a comprehensive profiling of over 30 companies actively involved in developing groundbreaking diagnostic solutions. These profiles include established industry giants as well as nascent players who are introducing innovation and driving growth in the AMR diagnostic space.
Apart from the technological evaluation and strategic market insights, the document delves into the trends influencing the global AMR diagnostics market from 2023 to 2027. It is instrumental for formulating data-driven decisions and aligning business strategies with the market dynamics.
The insights provided in the report are crucial for industry professionals, healthcare providers, and policy-makers who are navigating the challenges of antimicrobial resistance. It serves as a roadmap to understanding the evolving technologies and market strategies that will play a crucial role in the global healthcare system.
- Plain language analysis of the diverse diagnostic techniques
- Forecasted market data for major pathogen diagnostic opportunities
- Extensive company profiles spanning major industry participants
- Valuable perspectives on emerging trends and market growth areas
As the healthcare industry grapples with the enormity of antimicrobial resistance, this report is an essential resource providing clarity and direction for those at the forefront of medical diagnostics innovation.
Key Topics Covered:
Antibiotic Resistance Diagnostics Recent Developments
- Antibiotic Resistance Recent Developments
- FDA Clears New bioMerieux Diagnostic System and Panel
- Selux Diagnostics Phenotyping System Gets FDA Approval
- New diagnostics to tackle drug resistant infections
- Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Infectious Disease Panels
- Three companies join forces to tackle antimicrobial resistance (AMR)
- T2 Biosystems Exercises BARDA Option
- OpGen to Ramp up Use of Acuitas AMR Gene Panel
- BD Partners With Pfizer, Wellcome to Study AMR Dx
- Sepsis Test Developers Accelerate Plans
- OpGen Receives FDA Clearance for AMR Panel
- Visby Medical - Rapid Uptake of Handheld PCR Test for STIs
- MicroGenDx, OrthoKey Clinic and OrthoKey Surgery
- BioMerieux Receives CE Mark for Vitek Clinical Microbiology System
- Hologic to Acquire Mobidiag
- Campylobacter strains exchange genes
- Disinfection spreads antimicrobial resistance
- Molzym, Fraunhofer Developing Rapid Sepsis Dx
- Illumina, IDbyDNA Build NGS-Based Respiratory Panel
- Accelerate Diagnostics Expands AMR Testing
- Rapid diagnostics linked to optimal antibiotics
- Visby Medical Wins AMR Diagnostic Competition
- DNAe Technology SARS-CoV-2 Sequences
- Infections with foodborne bacteria becoming harder to treat
- Dust is sharing antibiotic resistance genes
Key AMR Diagnostics Companies
- 1928 Diagnostics
- Abacus Diagnostica
- Abbott Laboratories
- Accelerate Diagnostics
- ADT Biotech
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Binx Health
- bioMérieux Diagnostics
- Bio-Rad Laboratories, Inc.
- Cepheid (Danaher)
- Curetis N.V. / Curetis GmbH
- Day Zero Diagnostics.
- Enzo Biochem
- Eurofins Scientific
- Fusion Genomics.
- GeneFluidics
- Genetic Signatures
- Great Basin Corporation
- Hologic
- Hutman Diagnostics
- Inflammatix
- Linear Diagnostics.
- Lumos Diagnostics
- Millipore Sigma
- OpGen
- Ortho Clinical Diagnostics
- Perkin Elmer
- Qiagen
- Roche Molecular Diagnostics
- SeLux Diagnostics
- Sense Biodetection
- Siemens Healthineers
- Sysmex
- Thermo Fisher Scientific Inc.
- Visby Medical
The Global Market for Antimicrobial Resistance Diagnostics
Global Antibiotic Resistance Diagnostic Markets - By Pathogen
Global Antibiotic Resistance Diagnostic Markets - by Technology
Vision of the Future of AMR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/dm4ikm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
